Aehr Test Systems (NASDAQ: AEHR) reports Q2 results, reinstates guidance

Rhea-AI Filing Summary

Aehr Test Systems filed a current report to note that it issued a press release on January 8, 2026 announcing its financial results for the fiscal 2026 second quarter ended November 28, 2025. The company also used the release to communicate a reinstatement of its fiscal 2026 guidance. The press release is furnished as Exhibit 99.1 and is not deemed filed for liability purposes under certain securities laws.

0001040470false00010404702026-01-082026-01-08iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

January 8, 2026

AEHR TEST SYSTEMS

(Exact name of registrant as specified in its charter)

California		000-22893		94-2424084
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)
400 KATO TERRACE FREMONT, CA 94539
(Address of principal executive offices, including zip code)
510-623-9400
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	AEHR	The NASDAQ Capital Market

Item 2.02.  Results of Operations and Financial Condition.

On January 8, 2026, Aehr Test Systems, a California corporation (the “Company”), issued a press release announcing the Company’s financial results for its second quarter ended November 28, 2025.  A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in this Item 2.02 and Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.  Financial Statements and Exhibits.

(d)  Exhibits.

Exhibit No.		Description
99.1		Press Release dated January 8, 2026, announcing the Company's fiscal 2026 second quarter financial results and reinstatement of fiscal 2026 guidance
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AEHR TEST SYSTEMS
Date: January 8, 2026	By:	/s/ Chris P. Siu
		Chris P. Siu
		Executive Vice President of Finance and
		Chief Financial Officer

3

FAQ

What did Aehr Test Systems (AEHR) disclose in this 8-K filing?

Aehr Test Systems disclosed that it issued a press release announcing its financial results for the fiscal 2026 second quarter and the reinstatement of its fiscal 2026 guidance.

Which fiscal period’s results did Aehr Test Systems report?

The company reported financial results for its second quarter of fiscal 2026, which ended on November 28, 2025.

What is included as Exhibit 99.1 in the Aehr (AEHR) filing?

Exhibit 99.1 is the press release dated January 8, 2026 announcing Aehr Test Systems' fiscal 2026 second quarter financial results and the reinstatement of fiscal 2026 guidance.

Are the Aehr Test Systems Q2 2026 results considered filed financial information?

No. The information in Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not subject to certain liabilities under the Securities Exchange Act of 1934 or the Securities Act of 1933.

On which exchange is Aehr Test Systems common stock listed and under what symbol?

Aehr Test Systems common stock is listed on The NASDAQ Capital Market under the trading symbol AEHR.

Who signed the Aehr Test Systems 8-K related to fiscal 2026 Q2 results?

The report was signed on behalf of Aehr Test Systems by Chris P. Siu, Executive Vice President of Finance and Chief Financial Officer.